Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 37, 2003 - Issue 3
Submit an article Journal homepage
12
Views
9
CrossRef citations to date
0
Altmetric
Urology: Clinical research: ORIGINAL ARTICLE

Telomerase Activity in Diagnosis of Bladder Cancer*

Erım ErdemFrom the Departments of Urology, Hacettepe University Medical Faculty, Ankara, TurkeyCorrespondence[email protected]
,
Günnur DıkmenFrom the Departments of Biochemistry, Hacettepe University Medical Faculty, Ankara, Turkey
,
Necmettın AtsüFrom the Departments of Urology, Hacettepe University Medical Faculty, Ankara, Turkey
,
Pakıze DoğanFrom the Departments of Biochemistry, Hacettepe University Medical Faculty, Ankara, Turkey
&
Haluk ÖzenFrom the Departments of Urology, Hacettepe University Medical Faculty, Ankara, Turkey
Pages 205-209 | Received 24 Jul 2002, Accepted 05 Nov 2002, Published online: 24 Feb 2021

REFERENCES

  • Liu BCS, Loughlin KR. Telomerase in bladder cancer. Urol Clin North Am 2000; 27: 115-23.
  • Catalona WJ. Urothelial tumors of the urinary tract. In: Walsh PC. Retik AB. Stamey TA, Vaughan ED, eds. Campbell's urology. 6th edn.. Vol. 2. Philadelphia, PA: Saunders, 1992: 1094-152.
  • Prout GR Jr. Koontz WW Jr. Coombs J. Hawkins JR, Friedei GH. Long-term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not to receive thiotepa. J Urol 1987; 130: 677.
  • Lokeshwar VB, Block NL. HA-Haase urine test, a sensitive and specific method for detecting bladder cancer and evaluating its grade. Urol Clin North Am 2000; 27: 53-61.
  • Özen H. Bladder cancer. Curr Opin Oncol 1999; 11: 207-12.
  • Yokota K. Kanda K. Inoue Y. Kanayama H, Kagawa S. Semi-quantitative analysis of telomerase activity in exfoliated human urethelial cells and bladder transitional cell carcinoma. BJU Int 1998; 82: 727-32.
  • Dalbaghni G. Han W. Zhang Z, Cordon-Cardo C, Sarpo P. Fair WR, et al. Evaluation of the TRAP assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res 1997; 3: 1593-8.
  • Lancelin F. Anidjar M. Villette JM, Soliman A, Teillac P, Lie Duc A, et al. Telomerase activity as a potential marker in preneoplastic bladder lesions. BJU Int 2000; 85: 526-31.
  • Ramakumar S. Bluuyan J, Besse JA. Roberts SG, Woller PC. Blute ML, et al. Comparison of screening methods in detection of bladder cancer. J Urol 1999; 161: 388-94.
  • Hermonek P. Sobin LH. UICC-International Union Against Cancer. TNM classification of malignant tumors, 4th edn. Heidelberg, Germany: Springer-Verlag, 1987; 135.
  • Kim NW. Platsyek MA. Prowse KR. Harley CB, West MD, Ho PL, et al. Special association of human telomerase activity in immortal cells and cancer. Science 1994; 266: 2011-5.
  • Johnston B. Morales A. Emerson L, Lundie M. Rapid detection of bladder cancer: a comparative study of point of care tests. J Urol 1998; 158: 2098-101.
  • Landman J. Chang Y, Kavaler E, Droller MJ, Liu BC. Sensitivity and specificity of NMP-22, telomerase and BTA in the detection of bladder cancer. Urology 1998; 52: 398-402.
  • Sharma HW, Sokoloski JA, Perez JR. Maltese JY, Sartorelli AC, Stein CA, et al. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sei U S A 1995; 92: 12343-6.
  • Kavaler E, Landman J, Chang Y, Droller MJ, Liu BC. Detecting human bladder carcinoma cells in voiding urine samples by assaying for presence of telomerase activity. Cancer 1998; 82: 708-14.
  • Yoshida K, Takashi S, Hidetoshi T, Higashi Y, Kitahara S. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 1997; 79: 362-9.
  • Kinoshita H, Ogawa O, Kakehi Y, Mishina M, Mitsumoi K, Hoh N. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 1997; 89: 724-30.
  • Muller M, Heine B, Heicappel R, Miller K, Stein H. Telomerase activity in bladder cancer, bladder washings and in urine. Int J Oncol 1996; 9: 1169-73.
  • Zhang WW. Klotz L. Telomerase activity in needle biopsies from prostate cancer and benign prostates: the influence of sampling bias. Eur J Clin Invest 2000; 30: 275-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.